AZRX News and Press, AzurRx BioPharma Inc. From 03/31/21

DELRAY BEACH, Fla., March 31, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ: AZRX ), (“AzurRx” or the “Company”), a clinical stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestina...

Arcadia Biosciences RKDA +37% on Q4 results.ProPhase Labs PRPH +31% on VaccTrack acquisition.ClearOne CLRO +19% on Q4 results.Taoping TAOP +17% on share purchase agreement with Genie Global Limited.SPAR Group SGRP +16% on Q4 results.Greenlane ...

4 Biotech Penny Stocks For You End Of March Watch List Whether you’re a big fan of penny stocks or you’re trying to avoid them at all costs, there’s no denying the potential they have. There are very few things you can invest your money in and see quick & large ...

Support.com (SPRT) +271% as Greenidge Generation Holdings to go public via merger with the company.Seneca Biopharma (SNCA) +30%.Cemtrex (CETX) +21%.Marker Therapeutics (MRKR) +19%.Acer Therapeutics (ACER) +19%.Kansas City Southern (KSU) +17% as Canadian Pacific to buy the company fo...

AzurRx BioPharma (AZRX) has completed enrollment in its Phase 2 trial evaluating MS1819 in combination with the current standard of care, porcine-derived pancreatic enzyme replacement therapy ((PERT)), for the treatment of severe exocrine pancreatic insufficiency ((EPI)) in patients with...

DELRAY BEACH, Fla., March 22, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ: AZRX), (“AzurRx” or the “Company”), a clinical stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (GI)...

SunLink Health Systems (SSY) -24%.CHF Solutions (CHFS) -19% after plans to raise capital via public offering.Plug Power (PLUG) -18% on need to restate financial results.Zomedica (ZOM) -12%.Orbital Energy Group (OEG) -11%.Skillz (SKLZ) -10% on equity offering.NRG ...

Can-Fite BioPharma Ltd. (CANF) +87% on out-licensing psoriasis, liver disease drug rights.SunLink Health Systems, Inc. (SSY) +55% on announcing $2 Million expansion, capital and operating improvements at Trace Regional Hospital.Annovis Bio, Inc. (ANVS) +37% as ANVS401 improves ...

AzurRx BioPharma (AZRX) rise 14% premarket after completing enrollment for its Phase 2b OPTION 2 trial to investigate MS1819 in cystic fibrosis ((CF)) patients with exocrine pancreatic insufficiency.The trial enrolled 30 patients and top line data are anticipated by the end of Q1. T...

Top-line data expected by end of Q1 2021 DELRAY BEACH, Fla., March 16, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ: AZRX), (“AzurRx” or the “Company”), a clinical stage biopharmaceutical company specializing in the development of targe...